EQ
EQ
NASDAQ · Biotechnology

Equillium Inc

$1.75
-0.13 (-6.91%)
As of Mar 30, 10:09 PM ET ·
Financial Highlights (FY 2026)
Revenue
68.45M
Net Income
-13,439,175
Gross Margin
Profit Margin
-19.6%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 37.5% 37.5% 37.5%
Operating Margin -20.1% 14.3% 12.9% 13.2%
Profit Margin -19.6% 10.1% 10.1% 12.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 68.45M 35.55M 33.75M 28.19M
Gross Profit 13.33M 12.66M 10.57M
Operating Income -13,772,195 5.09M 4.35M 3.73M
Net Income -13,439,175 3.58M 3.41M 3.47M
Gross Margin 37.5% 37.5% 37.5%
Operating Margin -20.1% 14.3% 12.9% 13.2%
Profit Margin -19.6% 10.1% 10.1% 12.3%
Rev Growth -9.4% +19.8% -2.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 6.93M 6.88M 5.91M
Total Equity 59.04M 54.02M 49.55M
D/E Ratio 0.12 0.13 0.12
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -14,905,588 5.92M 5.34M 5.16M
Free Cash Flow 3.84M 3.54M 2.49M